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Introduction
Health care workers (HCW) in contact with patients in 
a contagious state of tuberculosis (TB) are at an increased 
risk of contracting TB infection when compared to the 
general population. The prevalence of latent tuberculosis 
infection (LTBI), a condition of ongoing immune response 
to Mycobacterium tuberculosis (MTB) without a progres-
sion to active TB disease1, ranges among HCW from 33 % 
to 79 % in low- and middle-income countries and from 5 % 
to 55 % in high income countries1,2. Early diagnosis and 
usage of adequate treatment is of a particular importance 
in controlling the TB3. Since 1948, the Childhood Vaccina-
tion Program in Croatia has included mandatory neonatal 
Bacillus Calmette-Guérin (BCG) vaccination4. In 2018, 
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A B S T R A C T
Health care workers (HCW) are at increased risk of a latent tuberculosis infection (LTBI) due to occupational exposure 
to Mycobacterium tuberculosis. In order to investigate the mutual influence of a TH1 type immune response caused by 
LTBI and T helper 2 (TH2) type immune response caused by allergy, we conducted a study examining the prevalence of 
common inhaled allergen sensitization in the HCW population with different levels of exposure to tuberculosis (high and 
low). HCW with possible exposure to tuberculosis (TB) were tested with QuantiFERON-TB Gold (QFT-G) and tuberculin 
skin test (TST), while skin prick test (SPT) was performed for inhaled allergens. The antigen (Ag) response at QFT-G was 
inversely correlated with participants̀  allergy anamnesis (p= 0.039). Sensitization to inhaled allergens (positive SPT and 
number of positive allergens at SPT) was more prominent in the low exposure group (p= 0.006 and p= 0.0065, respec-
tively). Ag response at QFT-G test was significantly higher in participants with no medical history of allergy (p= 0.048). 
Our results demonstrate that exposure to TB and LTBI are associated with inhaled allergen sensitization in HCW, pos-
sibly inhibiting allergic sensitization by mediating the T-helper type 1 (Th1) immune response.
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the overall incidence of TB in Croatia was 8.4/100.000 and 
350 TB cases were reported5.
It is reported that between up to 80 % of TB infections 
among HCW are associated to their occupational exposure 
to MTB6. MTB, the causative agent of TB, is a strong ac-
tivator of the T-helper type 1 (TH1) immune response, 
characterized by a strong cell-mediated immunity and 
production of interleukin-2 (IL-2), interferon-γ (IFN-γ) 
and tumor necrosis factor (TNF-α)7.
On the other hand, one of the hallmarks of allergic 
diseases, as an immune systems response against non-
hazardous substances of the environment, are production 
of allergen-specific immunoglobulin E (IgE) and prolifera-
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tion of allergen-specific T-cell populations (TH2 domi-
nant)8. The first phase of allergic disease development is 
the allergic sensitization. This refers to the process of ex-
cessive allergen-specific IgE production and its binding to 
the tissue mast cells and peripheral blood basophils via 
fragment crystallizable ε receptor I (FcεRI). Upon a re-
peated allergen exposure, antigen cross-linking of FcεRI 
occurs, and mast cells and basophils become activated 
causing allergic diseases development. Allergic sensitiza-
tion is manifested as immediate skin test reactivity. As 
opposed to TH1 type immune response, the TH2 type im-
mune response is defined by an increase in production of 
IL-4, -5, and -13, and a decrease in IFN-γ9. 
The hygiene hypothesis states that the TH1 and TH2 
type immune responses are inversely balanced10. Expo-
sure to microbial agents and subsequent infections are 
thought to stimulate TH1 immune response type and to 
promote the development of variety of regulatory T cells 
subpopulations, which are held responsible for securing a 
balanced immune response. Contrarily, in reduced micro-
bial exposure during early life, the predisposed individu-
als may develop TH2 type response to otherwise harmless 
antigens present in their environment11. 
Exposure to MTB is therefore thought to be a potential 
modifier of the TH1/TH2 balance and the onset and course 
of the allergic diseases. It might inhibit allergic sensitiza-
tion and clinical development of atopic allergic diseases by 
modifying the immune profile, i.e. downregulating unde-
sirable TH2 immune response by activation of regulatory 
T-cells and induction of anti-inflammatory cytokine re-
sponse12. However, little is known about the impact which 
exposure to MTB may have on allergic diseases develop-
ment and vice versa – data is scarce about potential influ-
ence which allergic sensitization may have on the develop-
ment and course of TB.
In order to provide more information about mutual in-
fluence of a TH1 type immune response caused by LTBI 
and TH2 type immune response caused by allergy we con-
ducted a study examining the prevalence of common in-
hallatory allergen sensitization and clinically relevant 
allergic disease in a HCW population with different levels 
of exposure to TB.
Subjects and Methods
Subjects
The study was conducted at Srebrnjak Children’s Hos-
pital in Zagreb, Croatia, which is the Ministry of Health 
Reference center for clinical allergy in children, with circa 
40–50 annual admissions of patients with TB. This study 
included 40 female HCW: nurses, laboratory technicians, 
physicians, physiotherapists and cleaning personnel with 
mean (SD) age of 44.1 (8.0) years (range 25–60 years), 
taking part in high or low risk work activities regarding 
TB transmission. They were recruited during the obliga-
tory yearly medical examination. The level of TB exposure 
broadly differs among health care occupations, so accord-
ing to the exposure of HCW to the patients in a contagious 
state of TB, they were divided in high risk (TB+) and low 
risk (TB–) subgroup. High risk subgroup included person-
nel from a tuberculosis ward for infants and children up 
to 7 years of age, and personnel from tuberculosis ward 
for school children and adolescents, which were directly 
exposed to tuberculosis patients during office hours for a 
period of time longer than 5 years. Low risk subgroup 
involved HCW from nontuberculosis wards without direct 
exposure to tuberculous patients. All participants were 
clinically healthy and with no history of clinically mani-
fested TB. They had all received mandatory BCG vaccina-
tion in childhood according to the national vaccination 
calendar, comprising neonatal vaccination with BCG vac-
cine SSI–0.0375 mg Mycobacterium bovis, Danish strain 
1331 (attenuated) dissolved in diluted Sauton SSI injected 
intradermally. All of them were retested at the age of 13 
in accordance with Croatià s Childhood Vaccination Pro-
gram and revaccinated later if necessary.
The study was approved by the Srebrnjak Children’s 
Hospital Ethics Committee. All subjects involved were 
acquainted with study objectives and the methods used 
and signed the informed consent for the study. The study 
protocol was executed according to the ethical principles 
of the World Medical Association Declaration of Helsinki13. 
Methods
Determination of blood IFN-γ was performed by the 
commercial QuantiFERON-TB Gold (QFT-G) (Cellestis/
Qiagen, Valencia, CA, USA). QFT-G is an IFN-γ release 
assay, commonly known as IGRA, and was used according 
to manufacturer’s instructions14. Prior to TST, blood was 
extracted for IFN-γ determination into three evacuated 
heparinized test tubes: antigen-free tube (nil or negative 
control); tube with specific antigens for MTB (ESAT-6, 
CFP-10 and TB7.7; TB antigen tube); and tube with mito-
gen phytohemagglutinin (PHA) (mitogen or positive con-
trol). Only samples with the required blood volume (1±0.1 
ml) were referred to the laboratory. Within 5 h of venipunc-
ture, all test tubes were incubated at 37 °C for 22 h. After 
incubation, the tubes were centrifuged and plasma was 
stored at +4 °C. The concentration of IFN-γ was determined 
within 7–10 days by enzyme-linked immunosorbent assay 
(ELISA) according to manufacturer’s instructions. IFN-γ 
concentration in the TB antigen tube and mitogen tube was 
reduced by the IFN-γ concentration in nil tube. The cut-off 
value for positive finding (TB antigen minus nil) was 0.35 
kIUl–1 and by ≥25 % higher than the nil value. The TB 
antigen tube finding was interpreted if the values of nega-
tive and positive control met the following criteria: nil <8.0 
kIUl–1 and mitogen minus nil ≥0.50 kIUl–1. The subjects 
with mitogen minus nil <0.50 kIUl–1 and/or nil negative 
control >8.0 kIUl–1 were classified as indeterminate.
Tuberculin skin test (TST) was performed by intrader-
mal injection of 2 tuberculin units (TU) of standardized 
PPD solution Tuberkulin RT23 SSI (Statens Serum Insti-
tut, Copenhagen, Denmark) on the volar surface of the left 
forearm. The transverse diameter of the indurated area 
was measured after 72 h. Induration diameter ≥15 mm 
was defined as a positive reaction. For all subjects, the test 
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was performed by the same trained professionals. No re-
peated TST were performed.
The presence of clinically manifested allergy (allergic 
rhinoconjunctivitis, atopic dermatitis, allergic asthma 
and/or food allergy) in personal medical history was self 
reported using a questionnaire. Besides covering above 
mentioned diseases and their associated symptoms, par-
ticipants gave detailed data on eventual use of allergy 
medication, previously conducted allergy tests, lifestyle 
habits and their sociodemographic characteristics.
Skin prick test (SPT) was performed after QFN-G and 
TST on the volar surface of the right forearm with extracts 
of 11 inhalant allergens: house dust mite (Dermatopha-
goides pteronysinnus), animal dander (dog and cat), cocks-
foot (Dactylis glomerata), mugwort (Artemisia vulgaris), 
ragweed (Ambrosia elatior), birch (Betula alba), hazel 
(Corylus avellana), Alternaria alternata, and Cladospo-
rium mix (Cladosporium cladosporioides and C. her-
barum), with histamine hydrochloride (10 mg/ml) and 
phenolated glycero-saline used as positive and negative 
controls (Stallergenes, Marcy l’Etoile, France). A mean 
wheal diameter of ≥3 mm was defined as a positive SPT 
reaction15. 
Statistics
Shapiro-Wilk’s normality test was used to test the dis-
tributions of induration size (mm) at TST, Ag response 
(U/L) at QFN-G and total positive urtica diameter (mm) 
at SPT for normality. Data with normal distribution were 
expressed by arithmetic mean and standard deviation 
(mean±SD), and those with asymmetric distribution by 
median and range.
Groups of participants positive vs. negative at TST, and 
groups of participants positive vs. negative at QFN-G were 
compared by Fisher’s exact test for the presence of allergy 
and positive SPT result (at least 1 positive allergen) and 
by Student’s t-test for age. Nonparametric Mann-Whitney 
U test was used to compare the same groups for total 
positive urtica diameter (mm) at SPT and groups of par-
ticipants positive vs. negative at SPT for induration size 
(mm) at TST and Ag response (U/L) at QFT-G. Spearman 
non-parametric test was used to assess the association 
between continuous variables.
All statistical tests were performed using GraphPad 
Prism 6.01 (GraphPad Software, La Jolla, CA, USA). Val-
ues of p<0.05 were considered statistically significant. 
Results
The determination of IFN-γ in the total population of 
BCG vaccinated HCW revealed an LTBI prevalence rate 
(positive QFT-G test) of 17/39 (43.59 %), with a median 
value for IFN-γ response upon TB antigen stimulation 
2.80 (range 0.40–12.41) kIU/L. Fourteen (35.90 %) par-
ticipants tested positive at TST with a median induration 
diameter of 23.5 (range 15–40) mm. No significant differ-
ence was found between groups of participants positive vs. 
negative at TST, and groups of participants positive vs. 
negative at QFT-G test for age (p=0.707; p=0.053), the 
history of allergy (p=0.458; p=0.701) and positive SPT 
result for at least 1 allergen (p=0.482; p=0.883) (Table 1).
Twelve (28.21 %) subjects were positive at SPT for at 
least 1 allergen with a median total positive urtica diam-
eter of 11 (range 4–27) mm, while 22 (56.41 %) subjects 
had a medical history of allergy (Table 1). IFN-g concen-
tration (Ag response at QFT-G) was inversely correlated 
with participants̀  allergy anamnesis (Spearman rho = 
–0.331, p = 0.039). Ag response (IFN-γ concentration) at 
QFT-G test was significantly higher in participants with 
a negative medical history of allergy (p = 0.048, Figure 1).
When comparing subgroups with high and low risk of 
TB exposure we found no significant difference history of 
allergy between these groups (p = 0.301), while a positive 
SPT to at least one allergen was more frequent in the low 
risk TB exposure group (p = 0.006, Table 2). The number 
of positive allergens at SPT was significantly higher in the 
low risk vs the high risk group of participants (p = 0.0065, 
Figure 2).
Discussion and Conclusion
The aim of this study was to examine the prevalence 
of allergen sensitization in health care workers with high 
or low risk of contracting the TB, and with positive or 
negative results at TST and QFT-G. We wanted to exam-
ine if there is a difference in the prevalence of allergic 
TABLE 1
RESULTS OF SKIN PRICK TEST, TUBERCULIN TEST AND QUANTIFERON GOLD TEST BY AGE AND ALLERGY 
DIAGNOSIS 
TST+ (n=14) TST- (n=25) Two-tailed/sided p-value QFT-G+ (n=17) QFT-G-(n=22) 
Two-tailed/
sided p-value
Age: mean±SD* 44.5.0±5.19 43.48±9.27 0.707 46.65±5.20 41.68±9.14 0.053
No. of subjects positive at SPT** 3 (21.43%) 8 (32.00%) 0.482 5 (29.40%) 6 (27.27%) 0.883
No. of subjects with allergy in 
personal medical record** 9 (64.29%) 13 (52.00%) 0.458 9 (52.94%) 13 (59.09%) 0.701
* unpaired t-test; ** Fisher’s exact test
QFT-G = Quantiferon-Tb Gold; SD = Standard Deviation; SPT = Skin Prick Test; TST = Tuberculin Skin Test.
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sensitization in HCW exposed to TB and conversely – will 
HCW with the presence of allergy be less susceptible to 
TB infection. As to our knowledge, this is the first study 
which underlines this question.
 Our results indicated the prevalence of LTBI in HCW 
to be lower than the respective literature data on health-
care professionals in low- and middle-income countries2 
not exceeding the World Health Organization estimates 
for the general world population18. Previously conducted 
study on HCW exposed to patients with TB in our facility 
demonstrated that the rate of IFN-γ positive HCW was 
not significantly higher in HCW at high exposure to TB 
infection16,17. This is probably due to the fact that children 
under 10 years of age rarely develop microscopically posi-
tive TB and forceful cough like adult patients do18, so HCW 
in childreǹ s hospital may be presumed to be less exposed 
to TB infection.
We found that QFT-G results (Ag response) were in-
versely correlated with the participants̀  personal medical 
history of allergy and that IFN-g concentrations were sig-
nificantly higher in participants with negative medical 
history of allergy. Additionally, when the participants 
were categorized into 2 groups according to their risk of 
exposure to TB (high and low risk), we found that a posi-
tive SPT result to at least one allergen was more common 
in in the low exposure group, as is consistent with our 
previous findings on paediatric population16. Moreover, the 
sensitization rate (number of allergens positive at SPT) 
was significantly higher in the low risk group of partici-
pants compared to those with high risk of exposure to TB. 
It is known that TH1 and TH2 responses are mainly mutu-
ally inhibitory and reciprocally regulated7. The so-called 
“hygiene hypothesis” suggests that early childhood expo-
sure to microorganisms and infections reduces suscepti-
bility to allergy by driving pro- or anti-inflammatory im-
mune responses20,21. Exposure to microbial agents and 
infections such as MTB stimulates the Th1 type of im-
mune response which is inversely balanced with Th2 re-
sponse characteristic for atopy allergy22. Continuous ex-
posure to pathogens results in the induction of regulatory 
pathways involved in the maintenance of immune toler-
ance tolerance through the interaction with the innate 
immunity, including regulatory T cells (Tregs), innate 
lymphoid cells (ILCs), dendritic cells (DCs), epithelial 
cells, effector lymphocytes, natural killer T cells (NKT) 
and B lymphocytes23. Additonally, microbial endotoxins 
are powerful adjuvants that can enhance these immune 
responses and serve as protective factors against the de-
velopment of allergy24,25.  Moreover, the ability of MTB to 
persist in the lungs throughout a patient ś lifetime, caus-
ing LTBI and preventing active disease forms by the host’s 
ongoing immune response, may indicate that a persistent 
immune challenge by pathogens immune system robust-
ness and reduces causes it not to overreact otherwise un-
harmful environmental agents (allergens). Indeed, previ-
Fig.1. Number of positive (pos) allergens at skin prick test (SPT) 
in participants with high or low exposure to TB patients. 
Mann-Whitney U test, median (0 mm) and interquartile range 
are shown. U = 103.5, p = 0.0065.
TABLE 2
THE NUMBER OF SUBJECTS POSITIVE AT SKIN PRICK TEST AND THE NUMBER OF SUBJECTS WITH ALLERGY 
IN THE PERSONAL MEDICAL RECORD IN SUBJECTS WITH HIGH (TB+) OR LOW (TB-) RISK OF EXPOSURE TO TB 
PATIENTS 
TB– (n=22) TB+ (n=17)
Two-sided 
p-value
No. of subjects positive at SPT* 10 (45.45%) 1 (5.88%) 0.006*
No. of subjects with allergy in personal medical record* 14 (63.64%) 8 (47.06%) 0.301
* Fisher’s exact test
TB = tuberculosis, SPT = skin prick test.
Fig. 2. Antigen response (IFN-γ concentrations, U/l) in 
participants with positive (Allergy +) vs. negative (Allergy-) 
personal medical history. Median (0 mm) and interquartile 
range are shown. U = 109.0, p = 0.048. Ag response = antigen 
response.
131
I. Banić et al.: Association of LTBI and Allergy in Health Workers, Coll. Antropol. 44 (2020) 3: 127–132
ous studies have shown that exposure to MTB may reduce 
the risk of developing asthma and other allergic diseases 
in both children and adults26–28.
Some precautions were made when planning the study. 
Because LTBI and active disease cannot be differentiated 
by IFN-γ determination, the possible presence of active TB 
was ruled out by normal clinical findings recorded in all 
our IFN-γ positive subjects. Participants with positive 
IFN-γ findings received no TB chemoprophylaxis and 
were free from any signs of TB at 1 year after testing. 
Repeated HCW testings to TB infection did not affect the 
results because in the testing algorithm QFT-G venipunc-
ture always precedes TST29. 
The small sample size as well as gender bias (only fe-
male participants) represent the biggest limitations of our 
study, especially for identifying differences between sub-
groups; however, every HCW from the tuberculosis ward 
in our institution was included in the study. Addtionally, 
a study involving adult patients revealed that the protec-
tive effect of exposure to TB or previous MTB infection 
against the development of asthma and other allergic dis-
eases later in life was only present in female participants, 
but not in males27. Existance of a period between MTB 
exposure and reaching the allergic sensitization status 
should be kept in mind as one of the possible shortcomings 
which may have had an effect on the study results. In ad-
dition, there is a discrepancy between SPT results and 
medical history on allergy which may indicate possible 
medical history ambiguity. Nevertheless, both of latter 
limitations have been taken into account when approach-
ing the analysis as they have been observed as indepen-
dent variables. 
In conclusion, the results of this study demonstrate 
that there is a significant difference in allergic sensitiza-
tion, SPT associated parameters and clinical manifesta-
tions of allergy in HCW with high vs low risk of exposure 
to TB patients. It is plausible that exposure to TB and 
LTBI may confer protection against allergic sensitization 
and allergic disease. Further studies involving larger 
groups of participants should be undertaken to confirm 
these associations in HCW exposed to TB.  
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LATENTNA TUBERKULOZNA INFEKCIJA U ZDRAVSTVENIH RADNIKA POVEZANA JE S 
ALERGIJAMA I SENZIBILIZACIJOM NA UOBIČAJENE INHALACIJSKE ALERGENE
S A Ž E T A K
Zdravstveni radnici imaju povećan rizik od latentne tuberkulozne infekcije (LTBI) zbog profesionalne izloženosti 
Mycobacterium tuberculosis. Kako bismo istražili međusobni odnos imunološkog odgovora posredovanog stanicama Th1 
uzorkovanog tuberkuloznom infekcijom i onog posredovanog limfocitima Th2 u alergijama, istražili smo prevalenciju 
senzibilizacije na uobičajene inhalacijske alergene u zdravstvenih radnika s različitim stupnjem rizika od izoloženosti 
tuberkulozi (visok i nizak stupanj). Izloženost tuberkulozi i LTBI u zdravstvenih radnika testirani su korištenjem 
QuantiFERON-TB Gold (QFT-G) i tuberkulinskog kožnog testa (TST), a senzibilizacija na inhalacijske alergene je 
utvrđena kožnim ubodnim testom. Antigenski (Ag) odgovor na QFT-G testu inverzno je korelirao s osobnom anamnezom 
alergija sudionika (p= 0.039). Senzibilizacija na inhalacijske alergene (pozitivan kožni ubodni test i broj pozitivnih 
alergena na kožnom ubodnom testu) bila je izraženija u skupini sudionika s niskim rizikom od izloženosti tuberkulozi 
(p= 0.006 and p= 0.0065, respektivno). Ag odgovor na QFT-G testu bio značajno viši u sudionika s negativnom osobnom 
anamnezom alergija (p= 0.048). Rezultati ove studije ukazuju na to kako su izloženost tuberkulozi i LTBI povezani sa 
senzibilizacijom na uobičajene inhalacijske alergene u zdravstvenih radnika, potencijalno inhibirajući alergijsku senzi-
bilizaciju indukcijom imunološkom odgovora posredovanog stanicama Th1.
